Critical Analysis of Ashmari
Abstract
Ashmari is the third most common and unpleasant urinary tract condition. The Ashmari stone's shape is comparable to the urolithiasis symptoms. Traditional signs of Ashmari include discomfort and urine obstruction. Acharaya Sushruta described it as one of the eight Astamahagadas, or illnesses, that are the most difficult to treat. It is among the most prevalent diseases that the Mutravahasarotas experience. The urolithiasis recurrence rate is close to 50%, even with current treatment options. Since urolithiasis is thought to be spreading over the globe at an increasing rate. The idea of urolithiasis is examined in this article from an ayurvedic perspective in order to better management of disease.
References
Kaviraj Kunjalal Bhishagratna, Sushruta Samhita. Vol- 1. Varanasi: Chaukamba orientalia; 2002.p.28(3/3)
Sharma R.K, Vaidya Bhagwan das. Charaka Samhita with Cakrapanidatta’s Ayurveda commentary. Vol-IV. Varanasi: Chaukamba Sanskrit Sansthan; 2004.p. 479(26/36-38)
Kaviraj Kunjalal Bhishagratna. Sushruta Samhita. Vol -1. Varanasi: Chaukamba Orientalia; 2004.p.28-30 (3/7-9)
Kaviraj Kunjalal Bhishagratna. Sushruta Samhita. Vol-1. Varanasi: Chaukamba Orientalia; 2004.p.31 (3/12)
Sharma R.K, Vaidya Bhagwan das. Charaka Samhita with Cakrapanidatta’s Ayurveda commentary. Vol-IV. Varanasi: Chaukamba Sanskrit Sansthan; 2004.p. 477 (26/32)
Kaviraj Kunjalal Bhishagratna, Sushruta Samhita. Vol- 1. Varanasi: Chaukamba orientalia; 2004.p.34 (24- 26)
Harita- Harita Samhita. Kshemaraj Shri Krishanadas’ shindi commentary. Mumbai: Sri Venkateshwar Mudralaya; 1984.p.398 (31/1)
Karpe PV. The concept of urolithiasis. Shiroda Goa: Gomantak Ayurveda Research centre; 2015.
The International Journal of Innovative Science & Technology affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJIST.
Download link for COPYRIGHT FORM